An Open-label Study to Investigate ECUR-506 in Male Babies Less Than 9 Months of Age With Neonatal Onset OTC Deficiency

Clinical trial NCT06255782 · RECRUITING

Trial details

NCT number: NCT06255782
Sponsor: iECURE, Inc.
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Ornithine Transcarbamylase Deficiency Ornithine Transcarbamylase Deficiency Disease Ornithine Carbamoyltransferase Deficiency (Disorder)Urea Cycle Disorders, Inborn

Start date: 2024-04-08
Primary completion: 2027-12-01
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.